Important dates 2022

DateAction
February 1, 2022
(23:59 PM)
Procedure for pre-applications is now closed
May 1, 2022
(23:59 PM)
Deadline for full applications (by approval of pre-application only)
May - October 2022Review procedure
End of November 2022Decision on grants 2022 by the Board of the LSBR

As from 2013, pre-applications are required. Only one pre-application per applicant allowed.
These pre-applications will be judged by the Scientific Advisory Board of the LSBR.
For pre-applications in the fellowship program of the LSBR, please contact the LSBR office.
Also find forms on downloads or contact the LSBR office.


Procedure

  • Electronic submission of pre-applications February 1 (23:59 hrs).
  • Within 6 weeks, the applicants will be informed whether their proposal has been rejected or can be extended to a full proposal. Submission date for the full proposal is May 1 (23:59 hrs).
  • Only one pre-application per applicant will be allowed.
  • As is the case for full proposals, only pre-applications that fulfill all formal LSBR criteria will be eligible to enter the procedure.
  • Full applications will only be accepted after an approved pre-application.

Grants

Research grants of the LSBR can only be obtained by scientists permanently employed by Dutch research institutes.

As from 2023 the maximum grant for a regular project proposal is 450,000 Euro.
A grant for a fellowship has a maximum of 700,000 Euro (5 year).

The total available budget in 2022 for project proposals (including 1 fellowship grant) is 2,300,000 Euro.

Project proposals bearing no or only a remote relationship to the aims of the LSBR will not be included in the selection procedure.


Scientific Aim

The Landsteiner Foundation for Blood Transfusion Research (LSBR) supports fundamental research, including clinical and experimental investigations, in the field of blood, blood derivatives, and blood (related) diseases, provided that these are related to transfusion or blood cell transplantation.

This scope spans a wide range of subjects in the field of hematology, including haematopoiesis, haemostasis, immunotherapy, transfusion medicine, and other issues relevant to the field.


New item on application form

Historically, limited attention has been paid to Sex as Biological Variable (SABV) in biomedical research. During the past decade, scientific research has shown that various areas benefit from integrating biological sex differences in research projects. In response to various international recommendations, the LSBR requires applicants to consider to what extent SABV may be relevant for their research proposals. Appropriate issues to address may include male and female subjects, tissues or cells, and the implications thereof for the proposed experimental design.
 
For more information on how to address sex as a variable into research proposals, please check:
https://genderfulresearchworld.com/ – for a comprehensive overview of background material and scientific articles, based on knowledge from the European Gendered Innovations Project and the Canadian CIHR Institute for Gender and Health (CIHR-IGH).